USE OF LEUCOCYTE‐POOR BLOOD COMPONENTS IN ACUTE MYELOBLASTIC LEUKAEMIA DOES NOT AFFECT DISEASE‐FREE SURVIVAL IN FIRST COMPLETE REMISSION | Publicación